Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

Current data suggests that coronavirus disease 2019 (COVID-19) survivors experience long-
lasting problems. It is not yet understood how long these symptoms last. The goal of this …

A significant proportion of COVID‐19 patients experience debilitating symptoms for months
after the acute infection. According to recent estimates, approximately 1 out of 10 COVID‐19 …

With the COVID-19 pandemic having lasted more than 3 years, concerns are growing about
prolonged symptoms and respiratory complications in COVID-19 survivors, collectively …

As the world transitions from the acute phase of the COVID-19 pandemic, a novel concern
has arisen—interstitial lung disease (ILD) as a consequence of SARS-CoV-2 infection. This …

Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a
novel coronavirus that caused an ongoing pandemic of a pathology termed Coronavirus …

Introduction Post-acute sequelae of COVID-19 seem to be an emerging global crisis.
Machine learning radiographic models have great potential for meticulous evaluation of post …

As COVID-19 continues, an increasing number of patients develop long COVID symptoms
varying in severity that last for weeks, months, or longer. Symptoms commonly include …

While ground-glass opacity, consolidation, and fibrosis in the lungs are some of the
hallmarks of acute SAR-CoV-2 infection, it remains unclear whether these pulmonary …

In late December 2019, severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-
2) was discovered following a cluster of pneumonia cases in Wuhan, China. During the early …